November 7, 2016
Bayer seeks approval for its liver cancer drug
Bayer on Monday announced the submission of applications to extend the marketing authorization for its oral multi-kinase inhibitor
Pharmaceuticals, Biotechnology and Life Sciences
Category: Asia
November 3, 2016
Strides, Mylan settle Regulatory and General Claims on Agila transaction, Strides gets $30M
Strides and Mylan have agree to settle Regulatory and General Claims on Agila transaction.
November 2, 2016
India’s Ajanta gets green light for its high blood pressure generic
Ajanta Pharma has gotten US FDA’s approval to launch its high blood pressure tablets Amlodipine
November 2, 2016
India’s Koanna gets UK’s MHRA OK for Imatinib tablets
India’s Koanna gets marketing approval from MHRA for Imatinib tablets
November 1, 2016
USFDA opens door to $30M market for India’s Strides Shasun’s HIV-1 infection tablets
India’s Strides Shasun Limited has received approval from the USFDA for Abacavir Tablets
October 25, 2016
Bangladesh’s Beximco gets its second US FDA product approval
Bangladesh-based Beximco, the largest country’s pharmaceutcals exporter, has received its second US FDA …
October 19, 2016
Beximco Pharmaceutical to declare cash and stock dividends at next AGM
A Bangladesh based, AIM listed Beximco Pharmaceuticals has announced that it would declare/approve 5% final Cash Dividend, 5% Stock Dividend and 10% Cash Dividend
March 7, 2016
Pharma crusader takes India’s drug regulators to court
One of India’s best-known whistleblowers, who exposed dangerous practices in the generic drug industry in 2013, is taking the country’s drugs regulators to court, accusing them of failing to enforce rules on drug safety in the $15 billion (11 billion pound) industry.
January 21, 2016
Glenmark Pharmaceuticals entering $130M market with two new generic medicines
Glenmark Pharmaceuticals entering $130M market with Actavis’ Potassium Cholire capsules and generics of Warner Chilcott’s Loestrin tablets
January 21, 2016
Indian Natco to sell Bristol-Myer Squibb’s hepatitis C medicine in 112 countries
Indian pharmaceutical company Natco Pharma Limited has signed a nonexclusive, royalty free licensing agreement with the Medicines Patent Pool and…